Showing 31 news articles about Generic medicines

Filters Content type: News Topic: Generic medicines

Some medicines are available both from the original manufacturer and from other manufacturers. Generic medicines contain the same active ingredient and meet the same safety requirements as the branded product, but are considerably cheaper.

Injectable & long-acting HIV treatment

Injectable HIV treatment unlikely to be arriving soon in the global south

News
2 August 2023
Injectable & long-acting PrEP

Cabotegravir long-acting PrEP out of reach for upper middle-income nations

News
8 February 2023
Finance & funding

Second-line treatment nearly nine times more expensive than first-line in upper-middle income countries

News
9 August 2022
Access to healthcare

Just six injections a year can prevent HIV: here’s what it will take for the world to afford them

News
2 August 2022
Generic medicines

ViiV Healthcare to allow 90 countries to access generic versions of HIV prevention shot

News
28 July 2022
Access to healthcare

South Africa could be among the last to rollout child-friendly dolutegravir

News
14 June 2022
Generic medicines

Voluntary licensing via the Medicines Patent Pool is saving hundreds of thousands of lives

News
9 February 2022
Generic medicines

Getting to 95-95-95: global use of HIV generics would result in large reductions in spending, new infections and deaths

News
9 July 2021
Finance & funding

To be cost-effective, injectable PrEP can only cost about $3000 more than US generic oral PrEP

News
15 March 2021
PrEP policies & guidelines

Far fewer people would get PrEP in the US if generic TDF/FTC is replaced with Descovy (TAF/FTC), cost-effectiveness study finds

News
9 March 2020
Finance & funding

Rapid adoption of generic HIV drugs could save NHS £7 billion by 2033

News
10 May 2019
HIV treatment for children & young people

Why has the uptake of lopinavir/ritonavir oral pellets for children been slow?

News
2 May 2019
Access to healthcare

Glimmers of hope: moving towards better HIV and TB treatment in eastern Europe

News
7 February 2019
Generic medicines

Generic PrEP bought online has correct amounts of emtricitabine and tenofovir

News
28 October 2018
PrEP programmes & uptake

Most PrEP users in Berlin obtained it from informal channels

News
2 October 2018
Finance & funding

NHS England saved £10 million by switching to generic anti-HIV drugs in 2016

News
30 April 2018
Generic medicines

Generic drugs for HIV treatment may save money, but barriers to prescription make savings elusive

News
7 February 2018
PrEP programmes & uptake

A year of generic PrEP could recoup its own cost within five years if effectiveness is high, Public Health England model finds

News
23 October 2017
Generic medicines

No evidence of reduced efficacy or increased side-effects when patients switch to generic drugs, comparison study finds

News
24 August 2017
Access to healthcare

Countries and donors should aim for new $90-$90-$90 target on HIV, hepatitis, TB drug prices, study shows

News
27 July 2017
Generic medicines

Switching from Atripla to generic-containing regimens can produce large cost savings

News
23 April 2017
PrEP science

Tests of online PrEP purchases by London clinic find no fakes, and adequate drug levels

News
26 October 2016
Access to healthcare

New $90-$90-$90 target needed for global viral hepatitis, HIV and TB treatment

News
24 October 2016
PrEP policies & guidelines

Dutch model finds PrEP for high-risk gay men is cost-effective at current prices and cost-saving at generic prices

News
27 September 2016